
Akari Therapeutics (AKTX) Stock Forecast & Price Target
Akari Therapeutics (AKTX) Analyst Ratings
Based on 5 analyst ratings
Buy
Strong Buy 80%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 20%
Akari Therapeutics (AKTX) has been analyzed by 5 analysts, with a consensus rating of Buy. 80% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 20% predict a Strong Sell.
This aggregate rating is based on analysts' research of Akari Therapeutics and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Akari Therapeutics and is not a guaranteed prediction by Public.com or investment advice.
Akari Therapeutics (AKTX) Analyst Forecast & Price Prediction
Get the latest Akari Therapeutics (AKTX) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in Akari Therapeutics (AKTX)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Akari Therapeutics (AKTX) Forecast
Analysts have given Akari Therapeutics (AKTX) a Buy based on their latest research and market trends.
According to 5 analysts, Akari Therapeutics (AKTX) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $5, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $5, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.